Day: June 4, 2020

Full analysis of the CLE part of the LILAC study reinforces positive top-line results; participants who received BIIB059 (anti-BDCA2) demonstrated statistically significant reduction of disease activity compared to those who received placeboSafety and tolerability data further support the continued development of BIIB059Results underscore Biogen’s efforts to develop and deliver novel disease-modifying therapeutic options for people impacted by lupus, a chronic autoimmune disease characterized by skin lesions and/or systemic manifestationsCAMBRIDGE, Mass., June 04, 2020 (GLOBE NEWSWIRE) — Today, Biogen Inc. (Nasdaq: BIIB) shared positive data from the 16-week cutaneous lupus erythematosus (CLE) portion of the Phase 2 LILAC study. The study evaluated the efficacy and safety of BIIB059, a fully humanized IgG1 monoclonal antibody (mAb)...

NEW YORK and TORONTO, June 04, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (the “Company” or “NexTech”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an emerging leader in augmented reality for eCommerce, AR learning applications, and virtual events is pleased to announce the launch of its new ARitize360 app now live and available for a FREE download on both iOS and Android. The app’s 3D scan technology will add to the revenue-generating power of its AR eCommerce solution and its recently launched 3D/AR advertising platform.App DEMO VideoThe company has chosen to be laser focused and so ARitize360 is initially geared to be marketed to the shoe and sneaker industry where 3D/AR photo realistic scans can be made at scale, and cost effectively, which has not been possible to accomplish to date. According to Grandview Research “The global...

BOSTON, June 04, 2020 (GLOBE NEWSWIRE) — Today, DraftKings Inc. (NASDAQ: DKNG) announced it is partnering with Bay Mills Resort & Casino to enter into a new market access deal, subject to the receipt of all applicable licenses and approvals, that will bring the number one-rated mobile sportsbook to sports fans across the state of Michigan. The DraftKings Sportsbook mobile app is currently available in Colorado, Indiana, Iowa, New Jersey, New Hampshire, Pennsylvania and West Virginia.“Through a commitment to provide customers with a premier sports betting experience, DraftKings is happy to partner with Bay Mills Resort & Casino,” said Ezra Kucharz, DraftKings’ Chief Business Officer. “The Great Lakes State presents a number of gaming opportunities and we look forward to collaborating with Bay Mills to provide residents...

TORONTO, June 04, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV:DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telemedicine company seeking to revolutionize the delivery of healthcare to patients, is pleased to announce that, effective at market open today, it has commenced trading its common shares on the TSX Venture Exchange (the “TSXV”).The Company will continue to trade under its symbol “DOC”. The CUSIP 18912C102 and ISIN CA18912C1023 will remain the same.   The Company’s common shares have been delisted from the Canadian Securities Exchange. Shareholders of the Company are not required to take any action with respect to their shareholdings in connection with the Company’s listing on the TSXV.Listed WarrantsFurther to the Company’s news release of June 2, 2020, the Company issued 10,678,900...

        ORION CORPORATION         PRESS RELEASE       4 JUNE 2020 at 2.30 p.m. EEST Orion is developing an immuno-oncology (IO) drug discovery platform in the national research and innovation consortium Cancer IOThe national research and innovation project Cancer IO started in May as a part of Business Finland’s Personalized Health Program. The project will develop new solutions to enhance immunotherapy treatments and support the introduction of new therapies. Orion is one of the companies participating in the project, and the aim is to develop and establish an immuno-oncology drug discovery platform (IO platform) at Orion.This project coordinated by the University of Helsinki will integrate a significant number of Finnish immuno-oncology projects, which will be carried out at the universities of Helsinki and Turku, three university hospitals...

ORION OYJ                          LEHDISTÖTIEDOTE              4.6.2020         KLO 14.30         Orion kehittää immuno-onkologian lääketutkimuksen alustan osana kansallista tutkimus- ja innovaatiohanke Cancer IO:aKansallinen tutkimus- ja innovaatiohanke Cancer IO aloitti toimintansa toukokuussa Business Finlandin Yksilöllistetyn terveyden -ohjelmassa. Hankkeessa kehitetään uudenlaisia ratkaisuja immunoterapiahoitojen tehostamiseksi ja tuetaan uusien hoitojen käyttöönottoa. Orion on yksi hankkeessa mukana olevista yrityksistä, ja projektissa on tavoitteena kehittää Orionilla immuno-onkologian lääketutkimuksen alusta (IO platform).Helsingin yliopiston koordinoima Cancer IO tuo yhteen merkittävän määrän suomalaisia immunoterapia-alan hankkeita, jotka tullaan toteuttamaan Helsingin ja Turun yliopistoissa, kolmessa yliopistosairaalassa,...

Borgarstjórn Reykjavíkur samþykkti á fundi sínum þann 2. júní tillögu borgarstjóra til borgarráðs frá 28. maí um hækkun á lánsfjáráætlun um 4.000 m.kr. vegna aukinna fjárfestinga á árinu 2020. Heimild til lántöku á árinu 2020 verður eftir samþykkt þessarar tillögu 10.000 m.kr.Nánari upplýsingar veitirHalldóra Káradóttir sviðsstjóri fjármála- og áhættustýringarsviðshalldora.karadottir@reykjavik.is

Opgørelsen er baseret på samme regnskabspraksis som årsrapporten for 2019.Opgørelsen er ikke revideret. Der tages forbehold for endelig opgørelse.Med venlig hilsenStrategic Investments A/SJens BlackAttachmentSI_12_2020_NAV310520_040620